Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
DNLI · NASDAQ · Biological Products, (No Diagnostic Substances)
$18.45+0.25 (+1.37%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Denali Therapeutics (DNLI) · oqro.io/stocks/DNLI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Temasek Holdings (Private) Ltd disclosed an increased position in DNLI for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Siren, L.L.C. disclosed an increased position in DNLI for Q4 2025SourceInsider trade · Traded Aug 12, 2025 · Filed Aug 15, 2025
Officer sold ~$40K of DNLI shares in the open marketSourceInsider trade · Traded Aug 12, 2025 · Filed Aug 15, 2025
Officer sold ~$40K of DNLI shares in the open marketSourceInsider trade · Traded Aug 13, 2025 · Filed Aug 15, 2025
Officer sold ~$12K of DNLI shares in the open marketSourceInsider trade · Traded Jul 9, 2025 · Filed Jul 11, 2025
CEO sold ~$7.43M of DNLI shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 23, 2025
Siren, L.L.C. disclosed a reduced position in DNLI for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Jan 31, 2025
Baillie Gifford & Co disclosed a reduced position in DNLI for Q4 2024SourceInsider trade · Traded Jan 6, 2025 · Filed Jan 9, 2025
CEO sold ~$592K of DNLI shares in the open marketSourceInsider trade · Traded Jan 7, 2025 · Filed Jan 9, 2025
CEO sold ~$159K of DNLI shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 9, 2025
Officer sold ~$248K of DNLI shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Temasek Holdings (Private) Ltd disclosed a reduced position in DNLI for Q3 2024SourceInsider trade · Traded Nov 11, 2024 · Filed Nov 13, 2024
Director sold ~$1.06M of DNLI shares in the open marketSourceInsider trade · Traded Nov 11, 2024 · Filed Nov 13, 2024
Director sold ~$871K of DNLI shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 12, 2024
Officer sold ~$366K of DNLI shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 22, 2024
CEO sold ~$1.11M of DNLI shares in the open marketSourceInsider trade · Traded Sep 30, 2024 · Filed Oct 2, 2024
Director sold ~$871K of DNLI shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 9, 2025
Officer sold ~$248K of DNLI shares in the open marketSourceInsider trade · Traded Jan 7, 2025 · Filed Jan 9, 2025
Director sold ~$69K of DNLI shares in the open marketSourceInsider trade · Traded Jan 7, 2025 · Filed Jan 9, 2025
Officer sold ~$60K of DNLI shares in the open marketSourceInsider trade · Traded Jan 7, 2025 · Filed Jan 9, 2025
Officer sold ~$60K of DNLI shares in the open marketSourceInsider trade · Traded Dec 31, 2024 · Filed Jan 3, 2025
Director sold ~$608K of DNLI shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 3, 2025
Director sold ~$64K of DNLI shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 12, 2024
Officer sold ~$90K of DNLI shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 12, 2024
Director sold ~$31K of DNLI shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 12, 2024
Officer sold ~$9.4K of DNLI shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 5, 2024
Baillie Gifford & Co disclosed a reduced position in DNLI for Q3 2024SourceInsider trade · Traded Nov 1, 2024 · Filed Nov 5, 2024
Director sold ~$83K of DNLI shares in the open marketSource